Comprehensive Cancer Profiling for Personalised Treatment in South Africa
When facing a cancer diagnosis, having precise information about your specific tumour can make all the difference in your treatment journey. The OncoPro 350 Gene TMB MSI Profile Test provides the detailed genetic insights South African patients need to work with their oncologists in developing targeted, effective treatment strategies.
Understanding Your OncoPro 350 Gene Test
This advanced cancer profiling test examines 350 cancer-related genes using cutting-edge next-generation sequencing technology. It provides two crucial measurements that help guide treatment decisions:
- Tumour Mutational Burden (TMB): Measures the number of mutations in your tumour cells, which can indicate how well your cancer might respond to immunotherapy
- Microsatellite Instability (MSI): Assesses DNA repair capabilities, helping identify cancers that may benefit from specific targeted therapies
The test analyses 1.65 Mb of DNA, providing comprehensive genetic information from your tumour tissue sample.
Who Should Consider This Advanced Cancer Test?
This test is particularly valuable for South African patients who:
- Have been diagnosed with solid tumours and are seeking personalised treatment options
- Want to understand if immunotherapy might be effective for their specific cancer type
- Have cancers that have been difficult to treat with standard therapies
- Are looking for comprehensive genetic information to guide treatment decisions
- Want to explore all available targeted therapy options
Many patients in Johannesburg, Cape Town, and Durban have found this test instrumental in developing more effective treatment plans.
Why This Test Matters for Your Cancer Journey
The OncoPro 350 Gene Test provides several key benefits that can significantly impact your treatment experience:
- Personalised Treatment Guidance: Helps your oncologist select therapies most likely to work for your specific cancer
- Immunotherapy Suitability: Identifies whether your cancer might respond well to immunotherapy treatments
- Comprehensive Genetic Insights: Provides detailed information about 350 cancer-related genes in a single test
- Treatment Confidence: Reduces uncertainty by providing data-driven treatment recommendations
- Potential Cost Savings: May help avoid ineffective treatments, saving both time and resources
Understanding Your Test Results
Your results will provide clear, actionable information that your oncologist can use to guide your treatment plan. The report includes:
- Detailed analysis of TMB levels and what they mean for immunotherapy response
- MSI status and implications for targeted therapy options
- Specific genetic mutations identified in your tumour
- Interpretation of how these findings relate to available treatment options
- Clear guidance for discussing results with your healthcare team
Our team ensures you have the support needed to understand your results and their implications for your care.
Transparent Pricing for Advanced Cancer Care
| Service | Regular Price | Special Price |
|---|---|---|
| OncoPro 350 Gene TMB MSI Profile Test | ZAR 23,400 |
Turnaround Time: Samples accepted daily by 11 am | Results in 45 working days
Sample Requirements: Formalin fixed paraffin embedded (FFPE) tissue block with at least 10% tumour tissue
Why Trust Oracle Genomics for Your Cancer Testing?
- Nationwide Coverage: Serving patients across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise: Tests supervised by experienced oncologists and genetic specialists
- Advanced Technology: Utilising next-generation sequencing for maximum accuracy
- Patient-Focused Care: Empathetic support throughout your testing journey
- Reliable Results: Commitment to delivering accurate, actionable information
Take Control of Your Cancer Treatment Today
Don’t leave your treatment decisions to chance. Get the comprehensive genetic information you need to work with your oncologist in developing the most effective treatment strategy.
Limited Time Offer: Save ZAR 2,600 on this comprehensive cancer profiling test. Take action today to get the insights that could transform your treatment journey.
